MedTrace Logo

Immunological Characteristics of Preclinical IBD

NCT05698745 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2026-04-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate disease progression, in terms of development of symptomatic disease and complications associated with IBD (e.g. fistula, abscess, stricture).

Conditions

Interventions

PROCEDURE

bioespecimen samples

Blood, serum, plasma, urine, stools, small/large bowel tissue.

Sponsors & Collaborators

  • Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

    lead OTHER

Principal Investigators

  • Iago Rodriguez Lago, MD · Spanish Working Group on Crohn's disease and ulcerative colitis (GETECCU)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2026-07-01
Completion
2038-07-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05698745 on ClinicalTrials.gov